UniProt ID | PLCG1_HUMAN | |
---|---|---|
UniProt AC | P19174 | |
Protein Name | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | |
Gene Name | PLCG1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1290 | |
Subcellular Localization | Cell projection, lamellipodium. Cell projection, ruffle. Rapidly redistributed to ruffles and lamellipodia structures in response to epidermal growth factor (EGF) treatment. | |
Protein Description | Mediates the production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). Plays an important role in the regulation of intracellular signaling cascades. Becomes activated in response to ligand-mediated activation of receptor-type tyrosine kinases, such as PDGFRA, PDGFRB, FGFR1, FGFR2, FGFR3 and FGFR4. Plays a role in actin reorganization and cell migration.. | |
Protein Sequence | MAGAASPCANGCGPGAPSDAEVLHLCRSLEVGTVMTLFYSKKSQRPERKTFQVKLETRQITWSRGADKIEGAIDIREIKEIRPGKTSRDFDRYQEDPAFRPDQSHCFVILYGMEFRLKTLSLQATSEDEVNMWIKGLTWLMEDTLQAPTPLQIERWLRKQFYSVDRNREDRISAKDLKNMLSQVNYRVPNMRFLRERLTDLEQRSGDITYGQFAQLYRSLMYSAQKTMDLPFLEASTLRAGERPELCRVSLPEFQQFLLDYQGELWAVDRLQVQEFMLSFLRDPLREIEEPYFFLDEFVTFLFSKENSVWNSQLDAVCPDTMNNPLSHYWISSSHNTYLTGDQFSSESSLEAYARCLRMGCRCIELDCWDGPDGMPVIYHGHTLTTKIKFSDVLHTIKEHAFVASEYPVILSIEDHCSIAQQRNMAQYFKKVLGDTLLTKPVEISADGLPSPNQLKRKILIKHKKLAEGSAYEEVPTSMMYSENDISNSIKNGILYLEDPVNHEWYPHYFVLTSSKIYYSEETSSDQGNEDEEEPKEVSSSTELHSNEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWRNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQEGQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDYGALYEGRNPGFYVEANPMPTFKCAVKALFDYKAQREDELTFIKSAIIQNVEKQEGGWWRGDYGGKKQLWFPSNYVEEMVNPVALEPEREHLDENSPLGDLLRGVLDVPACQIAIRPEGKNNRLFVFSISMASVAHWSLDVAADSQEELQDWVKKIREVAQTADARLTEGKIMERRKKIALELSELVVYCRPVPFDEEKIGTERACYRDMSSFPETKAEKYVNKAKGKKFLQYNRLQLSRIYPKGQRLDSSNYDPLPMWICGSQLVALNFQTPDKPMQMNQALFMTGRHCGYVLQPSTMRDEAFDPFDKSSLRGLEPCAISIEVLGARHLPKNGRGIVCPFVEIEVAGAEYDSTKQKTEFVVDNGLNPVWPAKPFHFQISNPEFAFLRFVVYEEDMFSDQNFLAQATFPVKGLKTGYRAVPLKNNYSEDLELASLLIKIDIFPAKENGDLSPFSGTSLRERGSDASGQLFHGRAREGSFESRYQQPFEDFRISQEHLADHFDSRERRAPRRTRVNGDNRL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAGAASPCA ------CCCCCCCCC | 27.86 | 19413330 | |
6 | Phosphorylation | --MAGAASPCANGCG --CCCCCCCCCCCCC | 21.70 | 25159151 | |
18 | Phosphorylation | GCGPGAPSDAEVLHL CCCCCCCCHHHHHHH | 49.25 | 26074081 | |
33 | Phosphorylation | CRSLEVGTVMTLFYS HHHCCCCCHHEEEEC | 16.57 | 23401153 | |
36 | Phosphorylation | LEVGTVMTLFYSKKS CCCCCHHEEEECCCC | 14.91 | 23401153 | |
39 | Phosphorylation | GTVMTLFYSKKSQRP CCHHEEEECCCCCCC | 23.77 | 23401153 | |
40 | Phosphorylation | TVMTLFYSKKSQRPE CHHEEEECCCCCCCC | 26.69 | 23401153 | |
43 | Phosphorylation | TLFYSKKSQRPERKT EEEECCCCCCCCCEE | 34.85 | 23401153 | |
54 | Ubiquitination | ERKTFQVKLETRQIT CCEEEEEEEEEEEEE | 29.80 | - | |
63 | O-linked_Glycosylation | ETRQITWSRGADKIE EEEEEEECCCHHCCC | 16.52 | 29351928 | |
68 | Ubiquitination | TWSRGADKIEGAIDI EECCCHHCCCCCEEH | 41.97 | - | |
93 | Phosphorylation | TSRDFDRYQEDPAFR CCCCHHHHCCCCCCC | 20.35 | - | |
159 | Ubiquitination | QIERWLRKQFYSVDR HHHHHHHHHCCCCCC | 42.46 | - | |
159 (in isoform 2) | Ubiquitination | - | 42.46 | - | |
162 | Phosphorylation | RWLRKQFYSVDRNRE HHHHHHCCCCCCCHH | 12.80 | 25839225 | |
175 | Ubiquitination | REDRISAKDLKNMLS HHCCCCHHHHHHHHH | 57.72 | - | |
175 (in isoform 2) | Ubiquitination | - | 57.72 | - | |
178 | Ubiquitination | RISAKDLKNMLSQVN CCCHHHHHHHHHHCC | 50.90 | 21906983 | |
178 (in isoform 2) | Ubiquitination | - | 50.90 | - | |
186 | Phosphorylation | NMLSQVNYRVPNMRF HHHHHCCCCCCCHHH | 17.71 | 22461510 | |
205 | Phosphorylation | LTDLEQRSGDITYGQ HHHHHHHHCCCCHHH | 40.28 | 28787133 | |
209 | Phosphorylation | EQRSGDITYGQFAQL HHHHCCCCHHHHHHH | 26.75 | 28787133 | |
210 | Phosphorylation | QRSGDITYGQFAQLY HHHCCCCHHHHHHHH | 14.84 | - | |
219 | Phosphorylation | QFAQLYRSLMYSAQK HHHHHHHHHHHHHHH | 12.16 | - | |
226 | Ubiquitination | SLMYSAQKTMDLPFL HHHHHHHHHCCCCCH | 45.60 | 21890473 | |
226 (in isoform 2) | Ubiquitination | - | 45.60 | - | |
236 | Phosphorylation | DLPFLEASTLRAGER CCCCHHHHCCCCCCC | 20.71 | - | |
237 | Phosphorylation | LPFLEASTLRAGERP CCCHHHHCCCCCCCC | 27.58 | - | |
304 | Phosphorylation | EFVTFLFSKENSVWN HHHHHHHCCCCCCHH | 41.00 | 24719451 | |
379 | Phosphorylation | PDGMPVIYHGHTLTT CCCCEEEEECCEEEE | 11.28 | - | |
389 | Ubiquitination | HTLTTKIKFSDVLHT CEEEEEEEHHHHHHH | 40.13 | 21890473 | |
389 | Ubiquitination | HTLTTKIKFSDVLHT CEEEEEEEHHHHHHH | 40.13 | 21890473 | |
412 | Phosphorylation | SEYPVILSIEDHCSI CCCCEEEEEEHHCHH | 16.89 | - | |
428 | Phosphorylation | QQRNMAQYFKKVLGD HHHHHHHHHHHHHCC | 14.08 | 22461510 | |
430 | Ubiquitination | RNMAQYFKKVLGDTL HHHHHHHHHHHCCCC | 36.72 | - | |
430 (in isoform 2) | Ubiquitination | - | 36.72 | - | |
431 | Ubiquitination | NMAQYFKKVLGDTLL HHHHHHHHHHCCCCC | 32.56 | 21890473 | |
431 | Ubiquitination | NMAQYFKKVLGDTLL HHHHHHHHHHCCCCC | 32.56 | 21890473 | |
431 (in isoform 2) | Ubiquitination | - | 32.56 | - | |
440 | Ubiquitination | LGDTLLTKPVEISAD HCCCCCCCCEEECCC | 47.22 | 21890473 | |
440 (in isoform 2) | Ubiquitination | - | 47.22 | - | |
451 | Phosphorylation | ISADGLPSPNQLKRK ECCCCCCCHHHHHHH | 41.34 | 25159151 | |
456 | Ubiquitination | LPSPNQLKRKILIKH CCCHHHHHHHHHHCH | 41.71 | - | |
456 (in isoform 2) | Ubiquitination | - | 41.71 | - | |
465 | Ubiquitination | KILIKHKKLAEGSAY HHHHCHHHHCCCCCC | 53.28 | - | |
465 (in isoform 2) | Ubiquitination | - | 53.28 | - | |
470 | Phosphorylation | HKKLAEGSAYEEVPT HHHHCCCCCCCCCCC | 21.12 | 21945579 | |
472 | Phosphorylation | KLAEGSAYEEVPTSM HHCCCCCCCCCCCHH | 17.83 | 21945579 | |
477 | Phosphorylation | SAYEEVPTSMMYSEN CCCCCCCCHHHCCCC | 34.14 | 21945579 | |
478 | Phosphorylation | AYEEVPTSMMYSEND CCCCCCCHHHCCCCH | 8.76 | 21945579 | |
481 | Phosphorylation | EVPTSMMYSENDISN CCCCHHHCCCCHHCH | 12.28 | 21945579 | |
482 | Phosphorylation | VPTSMMYSENDISNS CCCHHHCCCCHHCHH | 16.42 | 21945579 | |
487 | Phosphorylation | MYSENDISNSIKNGI HCCCCHHCHHHHCCE | 27.64 | 21945579 | |
489 | Phosphorylation | SENDISNSIKNGILY CCCHHCHHHHCCEEE | 28.31 | 21945579 | |
496 | Phosphorylation | SIKNGILYLEDPVNH HHHCCEEEEECCCCC | 13.21 | 26356563 | |
506 | Phosphorylation | DPVNHEWYPHYFVLT CCCCCCCCCEEEEEE | 4.16 | 26356563 | |
509 | Phosphorylation | NHEWYPHYFVLTSSK CCCCCCEEEEEECCE | 7.29 | 26356563 | |
513 | Phosphorylation | YPHYFVLTSSKIYYS CCEEEEEECCEEEEE | 26.17 | 26356563 | |
514 | Phosphorylation | PHYFVLTSSKIYYSE CEEEEEECCEEEEEC | 26.02 | 26356563 | |
515 | Phosphorylation | HYFVLTSSKIYYSEE EEEEEECCEEEEECC | 20.17 | 26356563 | |
518 | Phosphorylation | VLTSSKIYYSEETSS EEECCEEEEECCCCC | 12.50 | 28450419 | |
519 | Phosphorylation | LTSSKIYYSEETSSD EECCEEEEECCCCCC | 17.06 | 28450419 | |
520 | Phosphorylation | TSSKIYYSEETSSDQ ECCEEEEECCCCCCC | 16.40 | 28450419 | |
523 | Phosphorylation | KIYYSEETSSDQGNE EEEEECCCCCCCCCC | 29.49 | 25159151 | |
524 | Phosphorylation | IYYSEETSSDQGNED EEEECCCCCCCCCCC | 34.89 | 25159151 | |
525 | Phosphorylation | YYSEETSSDQGNEDE EEECCCCCCCCCCCC | 41.18 | 23927012 | |
539 | Phosphorylation | EEEPKEVSSSTELHS CCCCCCCCCCCCCCC | 21.47 | 25159151 | |
540 | Phosphorylation | EEPKEVSSSTELHSN CCCCCCCCCCCCCCC | 46.59 | 23186163 | |
541 | Phosphorylation | EPKEVSSSTELHSNE CCCCCCCCCCCCCCC | 20.56 | 23186163 | |
542 | Phosphorylation | PKEVSSSTELHSNEK CCCCCCCCCCCCCCC | 44.51 | 23927012 | |
546 | Phosphorylation | SSSTELHSNEKWFHG CCCCCCCCCCCCCCC | 60.35 | 23186163 | |
549 | Ubiquitination | TELHSNEKWFHGKLG CCCCCCCCCCCCCCC | 60.45 | - | |
554 | Ubiquitination | NEKWFHGKLGAGRDG CCCCCCCCCCCCCCH | 34.87 | - | |
554 (in isoform 2) | Ubiquitination | - | 34.87 | - | |
582 | Phosphorylation | ETGAPDGSFLVRESE HHCCCCCCEEEEECC | 23.84 | 28857561 | |
666 | Ubiquitination | QTNAHESKEWYHASL CCCCCCCHHHHHHHC | 49.64 | - | |
666 (in isoform 2) | Ubiquitination | - | 49.64 | - | |
669 | Phosphorylation | AHESKEWYHASLTRA CCCCHHHHHHHCHHH | 6.65 | - | |
701 | Phosphorylation | RKRNEPNSYAISFRA EECCCCCCEEEEEEE | 27.02 | 28152594 | |
702 | Phosphorylation | KRNEPNSYAISFRAE ECCCCCCEEEEEEEE | 18.00 | 28152594 | |
705 | Phosphorylation | EPNSYAISFRAEGKI CCCCEEEEEEEECCC | 10.66 | 28152594 | |
763 | Ubiquitination | INEEALEKIGTAEPD CCHHHHHHHCCCCCC | 47.49 | - | |
763 (in isoform 2) | Ubiquitination | - | 47.49 | - | |
766 | Phosphorylation | EALEKIGTAEPDYGA HHHHHHCCCCCCCCC | 31.18 | 21945579 | |
771 | Phosphorylation | IGTAEPDYGALYEGR HCCCCCCCCCCCCCC | 18.27 | 21945579 | |
775 | Phosphorylation | EPDYGALYEGRNPGF CCCCCCCCCCCCCCC | 18.79 | 21945579 | |
783 | Phosphorylation | EGRNPGFYVEANPMP CCCCCCCEEECCCCC | 11.86 | 25159151 | |
791 | Phosphorylation | VEANPMPTFKCAVKA EECCCCCCHHHHHHH | 29.49 | 21945579 | |
793 | Ubiquitination | ANPMPTFKCAVKALF CCCCCCHHHHHHHHH | 24.62 | - | |
793 (in isoform 2) | Ubiquitination | - | 24.62 | - | |
797 | Ubiquitination | PTFKCAVKALFDYKA CCHHHHHHHHHCHHC | 22.35 | - | |
797 (in isoform 2) | Ubiquitination | - | 22.35 | - | |
803 | Ubiquitination | VKALFDYKAQREDEL HHHHHCHHCCCCCHH | 39.63 | - | |
815 | Phosphorylation | DELTFIKSAIIQNVE CHHHHHHHHHHCCEE | 21.64 | 27251275 | |
823 | Ubiquitination | AIIQNVEKQEGGWWR HHHCCEEECCCCCCC | 49.74 | - | |
833 | Phosphorylation | GGWWRGDYGGKKQLW CCCCCCCCCCCEEEE | 30.51 | 25839225 | |
890 | Ubiquitination | IAIRPEGKNNRLFVF EEECCCCCCCEEEEE | 49.76 | - | |
890 (in isoform 2) | Ubiquitination | - | 49.76 | - | |
932 | Phosphorylation | KIREVAQTADARLTE HHHHHHHHHHHHCCC | 19.43 | 28509920 | |
941 | Ubiquitination | DARLTEGKIMERRKK HHHCCCCHHHHHHHH | 32.42 | 21890473 | |
941 | Acetylation | DARLTEGKIMERRKK HHHCCCCHHHHHHHH | 32.42 | 25953088 | |
941 | Ubiquitination | DARLTEGKIMERRKK HHHCCCCHHHHHHHH | 32.42 | 21890473 | |
941 (in isoform 2) | Ubiquitination | - | 32.42 | - | |
954 | Phosphorylation | KKIALELSELVVYCR HHHHHHHHHHEEEEE | 21.36 | - | |
959 | Phosphorylation | ELSELVVYCRPVPFD HHHHHEEEEECCCCC | 3.85 | - | |
972 | Phosphorylation | FDEEKIGTERACYRD CCHHHHCCCCHHCCC | 26.27 | 24719451 | |
977 | Phosphorylation | IGTERACYRDMSSFP HCCCCHHCCCHHHCC | 14.52 | 25159151 | |
981 | Phosphorylation | RACYRDMSSFPETKA CHHCCCHHHCCHHHH | 32.87 | 30576142 | |
982 | Phosphorylation | ACYRDMSSFPETKAE HHCCCHHHCCHHHHH | 37.88 | 30576142 | |
987 | Acetylation | MSSFPETKAEKYVNK HHHCCHHHHHHHHHH | 53.54 | 25953088 | |
987 | Ubiquitination | MSSFPETKAEKYVNK HHHCCHHHHHHHHHH | 53.54 | - | |
987 (in isoform 2) | Ubiquitination | - | 53.54 | - | |
990 | Acetylation | FPETKAEKYVNKAKG CCHHHHHHHHHHHHC | 60.40 | 25953088 | |
991 | Phosphorylation | PETKAEKYVNKAKGK CHHHHHHHHHHHHCC | 10.76 | - | |
999 | Acetylation | VNKAKGKKFLQYNRL HHHHHCCHHHHHCCE | 61.03 | 25953088 | |
1003 | Phosphorylation | KGKKFLQYNRLQLSR HCCHHHHHCCEEHHC | 12.37 | 29496907 | |
1079 | Ubiquitination | EAFDPFDKSSLRGLE CCCCCCCHHHCCCCC | 42.18 | - | |
1079 (in isoform 2) | Ubiquitination | - | 42.18 | - | |
1128 | Phosphorylation | YDSTKQKTEFVVDNG CCCCCCEEEEEECCC | 31.96 | 22468782 | |
1150 | Phosphorylation | KPFHFQISNPEFAFL CCEEEEECCCCEEEE | 35.23 | 22468782 | |
1162 | Phosphorylation | AFLRFVVYEEDMFSD EEEEEEEEEHHHCCC | 14.32 | - | |
1193 | Ubiquitination | GYRAVPLKNNYSEDL CEEEEECCCCCCCCH | 36.76 | - | |
1193 (in isoform 2) | Ubiquitination | - | 36.76 | - | |
1196 | Phosphorylation | AVPLKNNYSEDLELA EEECCCCCCCCHHHH | 23.88 | 29496907 | |
1215 (in isoform 2) | Ubiquitination | - | 52.53 | - | |
1221 | Phosphorylation | AKENGDLSPFSGTSL CCCCCCCCCCCCCCH | 28.74 | 19664994 | |
1222 (in isoform 2) | Phosphorylation | - | 34.42 | 30266825 | |
1224 | Phosphorylation | NGDLSPFSGTSLRER CCCCCCCCCCCHHHC | 44.54 | 30266825 | |
1225 (in isoform 2) | Phosphorylation | - | 21.50 | 27987026 | |
1226 | Phosphorylation | DLSPFSGTSLRERGS CCCCCCCCCHHHCCC | 24.32 | 30266825 | |
1227 | Phosphorylation | LSPFSGTSLRERGSD CCCCCCCCHHHCCCC | 29.02 | 30266825 | |
1227 (in isoform 2) | Phosphorylation | - | 29.02 | 27987026 | |
1228 (in isoform 2) | Phosphorylation | - | 7.09 | 22199227 | |
1231 | Methylation | SGTSLRERGSDASGQ CCCCHHHCCCCCCCC | 43.40 | 115487745 | |
1233 | Phosphorylation | TSLRERGSDASGQLF CCHHHCCCCCCCCCC | 35.90 | 25159151 | |
1236 | Phosphorylation | RERGSDASGQLFHGR HHCCCCCCCCCCCCC | 31.87 | 23927012 | |
1243 | Methylation | SGQLFHGRAREGSFE CCCCCCCCCCCCCCH | 23.15 | 115487755 | |
1248 | Phosphorylation | HGRAREGSFESRYQQ CCCCCCCCCHHHCCC | 22.53 | 23401153 | |
1251 | Phosphorylation | AREGSFESRYQQPFE CCCCCCHHHCCCCHH | 33.99 | 29255136 | |
1253 | Phosphorylation | EGSFESRYQQPFEDF CCCCHHHCCCCHHHC | 22.30 | 23927012 | |
1263 | Phosphorylation | PFEDFRISQEHLADH CHHHCCCCHHHHHHH | 25.84 | 23401153 | |
1273 | Phosphorylation | HLADHFDSRERRAPR HHHHHCCCCCCCCCC | 34.79 | 29255136 | |
1283 | Methylation | RRAPRRTRVNGDNRL CCCCCCCCCCCCCCC | 20.35 | 115487765 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
771 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
771 | Y | Phosphorylation | Kinase | EGFR | P00533 | PSP |
771 | Y | Phosphorylation | Kinase | SYK | Q15046 | PhosphoELM |
771 | Y | Phosphorylation | Kinase | LCK | P06239 | GPS |
771 | Y | Phosphorylation | Kinase | SYK | P43405 | Uniprot |
783 | Y | Phosphorylation | Kinase | SYK | P43405 | Uniprot |
783 | Y | Phosphorylation | Kinase | TXK | P42681 | Uniprot |
783 | Y | Phosphorylation | Kinase | SYK | Q15046 | PhosphoELM |
783 | Y | Phosphorylation | Kinase | RET | P07949 | PSP |
783 | Y | Phosphorylation | Kinase | PDGFRB | P09619 | PSP |
783 | Y | Phosphorylation | Kinase | LCK | P06239 | GPS |
783 | Y | Phosphorylation | Kinase | ITK | Q08881 | Uniprot |
783 | Y | Phosphorylation | Kinase | EGFR | P00533 | PSP |
1003 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
1248 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
1248 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
1248 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
1248 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
1248 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
1253 | Y | Phosphorylation | Kinase | EGFR | P00533 | PhosphoELM |
- | K | Ubiquitination | E3 ubiquitin ligase | CBLB | Q13191 | PMID:15308098 |
- | K | Ubiquitination | E3 ubiquitin ligase | CBL | P22681 | PMID:16467851 |
- | K | Ubiquitination | E3 ubiquitin ligase | ITCH | Q96J02 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | PRKN | O60260 | PMID:18671761 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PLCG1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PLCG1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-6 AND SER-525, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-771; TYR-775; TYR-783;SER-1221; TYR-1253 AND SER-1263, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-6 AND SER-525, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1221, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1263, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-771; TYR-775 ANDTYR-783, AND MASS SPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-771; TYR-783 ANDTYR-1253, AND MASS SPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-977, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-771 AND TYR-1253, ANDMASS SPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-771 AND TYR-775, ANDMASS SPECTROMETRY. | |
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-775 AND TYR-783, ANDMASS SPECTROMETRY. | |
"Vascular endothelial growth factor (VEGF)-D and VEGF-A differentiallyregulate KDR-mediated signaling and biological function in vascularendothelial cells."; Jia H., Bagherzadeh A., Bicknell R., Duchen M.R., Liu D., Zachary I.; J. Biol. Chem. 279:36148-36157(2004). Cited for: PHOSPHORYLATION AT TYR-783 IN RESPONSE TO KDR ACTIVATION. | |
"Membrane raft-dependent regulation of phospholipase Cgamma-1activation in T lymphocytes."; Veri M.C., DeBell K.E., Seminario M.C., DiBaldassarre A., Reischl I.,Rawat R., Graham L., Noviello C., Rellahan B.L., Miscia S.,Wange R.L., Bonvini E.; Mol. Cell. Biol. 21:6939-6950(2001). Cited for: PHOSPHORYLATION AT TYR-783, AND SUBCELLULAR LOCATION. | |
"Phospholipase C-gamma1 interacts with conserved phosphotyrosylresidues in the linker region of Syk and is a substrate for Syk."; Law C.L., Chandran K.A., Sidorenko S.P., Clark E.A.; Mol. Cell. Biol. 16:1305-1315(1996). Cited for: PHOSPHORYLATION AT TYR-771 AND TYR-783 BY SYK, AND INTERACTION WITHSYK. |